Introduction:
Dabigo 75mg Capsule is a prescription medicine manufactured by Sun Pharmaceutical Industries Ltd. It contains the active ingredient Dabigatran Etexilate (75mg). This medication belongs to the therapeutic class of CARDIAC drugs and is a direct thrombin inhibitor taken orally. Dabigo 75mg Capsule is commonly used for the treatment and prevention of blood clots.
Uses:
Dabigo 75mg Capsule is primarily used for the treatment and prevention of blood clots. It is prescribed to patients at risk of conditions such as deep vein thrombosis, pulmonary embolism, and stroke. By inhibiting the action of thrombin, Dabigo helps prevent the formation of blood clots, thereby reducing the risk of serious cardiovascular events.
Price:
The Maximum Retail Price (MRP) of Dabigo 75mg Capsule is ₹115 for a strip containing 10 capsules. Prices may vary depending on the location and pharmacy.
Dosage:
It is important to take Dabigo 75mg Capsule as prescribed by your doctor. The dosage and duration of treatment will be determined based on your medical condition and response to therapy. This medication can be taken with or without food, but it is recommended to take it at the same time each day to maintain consistent levels in your bloodstream.
Benefits:
The primary benefit of Dabigo 75mg Capsule is its effectiveness in preventing and treating blood clots. By targeting thrombin, this medication helps reduce the risk of potentially life-threatening conditions such as strokes, pulmonary embolism, and deep vein thrombosis. It offers a convenient and effective option for patients requiring anticoagulant therapy.
Side Effects:
While Dabigo 75mg Capsule is generally well-tolerated, some patients may experience side effects. Common side effects may include bleeding, nausea, stomach pain, and indigestion. It is important to report any unusual or persistent side effects to your healthcare provider.
Active Ingredients:
The active ingredient in Dabigo 75mg Capsule is Dabigatran Etexilate. This compound works by inhibiting thrombin, a key enzyme involved in the clotting process. By blocking thrombin activity, Dabigo helps prevent the formation of clots in the blood vessels.
Pharmacological Properties:
Dabigatran Etexilate, the active ingredient in Dabigo 75mg Capsule, is a benzimidazole derivative with anticoagulant properties. It acts as a direct thrombin inhibitor, specifically targeting the enzyme thrombin to prevent the conversion of fibrinogen to fibrin. This mechanism of action interferes with the blood clotting cascade, reducing the risk of thrombus formation.
Indications:
Dabigo 75mg Capsule is indicated for the treatment and prevention of blood clots in patients at risk of thromboembolic events. It may be prescribed for conditions such as atrial fibrillation, deep vein thrombosis, and pulmonary embolism. Your doctor will determine the specific indication for which Dabigo is most suitable based on your medical history and risk factors.
Contraindications:
Dabigo 75mg Capsule is contraindicated in patients with a known hypersensitivity to Dabigatran Etexilate or any other components of the formulation. It should not be used in individuals with active bleeding, severe kidney disease, or artificial heart valves. Caution is advised in patients with liver impairment or a history of gastrointestinal bleeding.
Drug Interactions:
It is important to inform your healthcare provider about all medications, supplements, and herbal products you are taking before starting Dabigo 75mg Capsule. This medication may interact with other anticoagulants, antiplatelet agents, nonsteroidal anti-inflammatory drugs (NSAIDs), and certain antibiotics. Drug interactions can affect the effectiveness and safety of Dabigo, so your doctor will need to monitor your treatment closely.
Patient Counseling:
Patient counseling is essential for the safe and effective use of Dabigo 75mg Capsule. Patients should be advised to take the medication exactly as prescribed by their doctor and to follow all instructions regarding dosing and monitoring. It is important to report any unusual symptoms or side effects to your healthcare provider promptly. Regular follow-up appointments and laboratory tests may be necessary to monitor your response to treatment.
Clinical Evidence:
Clinical studies have demonstrated the efficacy and safety of Dabigo 75mg Capsule in the prevention and treatment of thromboembolic events. In trials comparing Dabigatran Etexilate with traditional anticoagulants, Dabigo has shown similar or superior outcomes in terms of reducing the risk of stroke, embolism, and major bleeding events. Consult your healthcare provider for more information on the clinical evidence supporting the use of Dabigo in your specific medical condition.
Frequently Asked Questions (FAQs):
1. Is Dabigo 75mg Capsule habit-forming?
No, Dabigo 75mg Capsule is not habit-forming. It does not cause dependence or addiction when used as prescribed by your doctor.
2. Can I take Dabigo with other medications?
It is important to consult your healthcare provider before taking Dabigo 75mg Capsule with other medications. Certain drugs, including anticoagulants, antiplatelet agents, and NSAIDs, may interact with Dabigatran Etexilate, affecting its effectiveness and safety.
3. What should I do if I miss a dose of Dabigo?
If you miss a dose of Dabigo 75mg Capsule, take it as soon as you remember. However, if it is close to the time of your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not double the dose to make up for a missed one.
4. Are there any dietary restrictions while taking Dabigo?
While there are no specific dietary restrictions associated with Dabigo 75mg Capsule, it is advisable to maintain a balanced diet and avoid excessive intake of foods high in vitamin K, as they can interfere with the anticoagulant effects of Dabigatran Etexilate.
5. How long should I continue taking Dabigo?
Your doctor will determine the duration of treatment with Dabigo 75mg Capsule based on your medical condition and individual risk factors. It is important to follow your doctor’s recommendations and not discontinue the medication without consulting them first.
For more personalized information about Dabigo 75mg Capsule and its use, consult your healthcare provider.
MRP:
₹115
Manufacturer:
Sun Pharmaceutical Industries Ltd
Salt:
Dabigatran Etexilate (75mg),
How to UseDabigo 75mg Capsule:
Take this medicine in the dose and duration as advised by your doctor. Dabigo 75mg Capsule may be taken with or without food, but it is better to take it at a fixed time.
Side Effects of Dabigo 75mg Capsule:
Bleeding,Nausea,Stomach pain,Indigestion,
Alternate Medicines for Dabigo 75mg Capsule:
Dabiten 75mg Capsule,Dabitra 75mg Capsule,Dabipack 75 Capsule,Goodflo 75mg Capsule,Dabirock 75mg Capsule,
Prescription Required Status:
Prescription Required
Type of Selection:
10 capsules in 1 strip
Chemical Class:
Benzimidazole derivative
Habit Forming:
No
Therapeutic Class:
CARDIAC
Action Class:
Direct thrombin inhibitor- oral
. Please note, this information is for educational purposes only and not intended as medical advice.
